ABSTRACT Low concentrations (0.5-1 puM) of cytochalasins inhibit the thrombin-stimulated polymerization of monomeric actin to filamentous actin in platelets. Similar concentrations of cytochalasin B inhibit the formation and metabolism of arachidonic acid in horse platelets stimulated by low concentrations of thrombin (0.1-0.5 unit/ml). However, the release of serotonin is not inhibited by cytochalasin B. Cytochalasins B and D (0.5-1 JAM) markedly reduce, in thrombin-stimulated human or horse platelets, the metabolism of the liberated arachidonic acid by cyclooxygenase activity to thromboxane B2 and 12-hydroxy-5,8,10-heptadecatrienoic acid and the conversion of arachidonic acid by lipoxygenase activity to 12-hydroxy-5,8,10,14-icosatetraenoic acid. The generation of arachidonic acid from platelet phospholipids and the formation of phosphatidic acid are much less affected by cytochalasin B or D. Cytochalasins do not directly inhibit platelet cyclooxygenase, lipoxygenase, phospholipase A2, or phosphatidylinositol-specific phospholipase C. In addition, the metabolism of exogenously added arachidonic acid by intact platelets is not inhibited by cytochalasins B and D. The results indicate that polymerization of actin in platelets stimulated by thrombin may be required for the effective metabolism of arachidonic acid released from platelet phospholipids.
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Polymerization of monomeric actin to filamentous actin occurs rapidly after stimulation of platelets with thrombin (1) (2) (3) . Actin polymerization may be related to the early morphological change of platelets from discoid, smooth-shaped cells to spiny spheres with protrusion of pseudopods (4, 5) , which precedes platelet responses such as spreading, adhesion, and aggregation.
Cytochalasins are fungal metabolites that inhibit actin polymerization by binding to the growing end ofactin filaments and blocking the further addition ofmonomeric actin molecules (6) (7) (8) (9) . It has been shown (5, 10) that cytochalasins inhibit actin polymerization or induce depolymerization of formed actin filaments in thrombin-stimulated platelets. Cytochalasins are reported to inhibit platelet shape change and, in higher concentrations, could also prevent platelet adhesion and aggregation (11) (12) (13) . However, the results concerning the effects of cytochalasins on the release of serotonin from platelets are controversial (14, 15) .
Another early biochemical response to platelet stimulation is the activation of phospholipases C and A2. Stimulation of phospholipase C leads to the formation of 1,2-diacylglycerol and phosphatidic acid, both ofwhich may play a role as intracellular mediators (16) (17) (18) . Stimulation ofphospholipases A2 leads to the liberation of arachidonic acid from membrane phospholipids and the immediate degradation of arachidonic acid by cyclooxygenase and lipoxygenase (19) . The formation of endoperoxides and thromboxanes in activated platelets has been implicated in platelet aggregation and serotonin release.
In this work we studied the possible correlation between changes in lipids and cytoskeleton in thrombin-stimulated platelets. Cytochalasins reduce actin polymerization and, also, the metabolism ofarachidonic acid in thrombin-activated platelets.
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1.0 ml of chloroform and 1.0 ml of water. The lower phase was dried under nitrogen, and arachidonic acid metabolites were separated by thin-layer chromatography as described (21) . Specific areas were localized by autoradiography, and`4C radioactivity was measured by liquid scintillation counting.
Preparation of Washed Human Platelets Labeled with
[14C]Arachidonic Acid. Platelets were prepared from fresh human blood treated to prevent coagulation with 0.15 vol of the citric acid/citrate/dextrose buffer. Blood donors had not received any medication in the previous 4 wk. Platelet-rich plasma (pH 6.4) was obtained by centrifugation at 200 x g for 20 min. Prostacyclin (PGI2) was used for the separation ofplatelets from plasma to prevent activation of human platelets (22) . Isolation ofplatelets was performed at room temperature. Platelet-rich plasmawas labeled with [ 4C]arachidonic acid (0.25 ,uCi/ ml) for 25 min at 37TC. Then, PGI2 (5 ng/ml) was added, and the platelets were centrifuged at 800 x g for 15 min. Platelets were resuspended and washed twice in buffer (134 mM NaCl/ 12 mM NaHCO3/2.9 mM KCl/0.36 mM NaH2PO4/5 mM Hepes/5 mM glucose/i mM EDTA, pH 7.4) containing PGI2 (300 ng/ml) by centrifugation at 600 X g for 10 min. Platelets were finally resuspended in buffer without PGI2, the concentration being adjusted to 7.5 x 108 platelets per ml. Platelets were used 20 min after final resuspension. Samples (0.5 ml) were preincubated with Me2SO (final concentration, 0.2%) or cytochalasin D for 5 min at 37°C in a shaking incubator water bath and were stimulated with thrombin (0.2 unit/ml). Incubations were stopped, and lipids were extracted by adding 3. (23) . Phospholipase C activity was assayed in the supernatant separated from homogenized horse platelets by centrifugation at 100,000 X g. Assays contained 20 ,ug of cytosolic protein, 0.5 mM L-phosphatidyl['4C]inositol, and 1 mM Ca2O in 0.1 ml of buffer (25 mM Tris maleate/100 mM NaCl, pH 5.5). After 5 min, reactions were stopped with 0.37 ml of 1:2 chloroform/ methanol, and phases were partitioned by the addition of 0.12 ml of chloroform and 0.12 ml ofwater.
[14C]Inositol phosphates produced during the reaction were measured in the upper, aqueous phase by liquid scintillation counting. Phospholipase A2 was assayed in the particulate fraction separated at 100,000
x g from homogenized horse platelets. Assays contained 75 ,ug of membrane protein, 0.5 mM L-a-phosphatidyl[14C]inositol, and 1 mM Ca2' in 0.1 ml of 0.1 M Tris (pH 9.0). After 10 min, reactions were stopped with 0.37 ml of chloroform/methanol/ concentrated HC1, 100:200:2 (vol/vol), followed by addition of 0.12 ml of chloroform and 0.12 ml of 2 M KC1 and separation of the phases. Lipids from the lower phases were dried under N2 and phosphatidylinositol was separated from lysophosphatidylinositol on thin-layer chromatography (24) . X-100/137 mM NaCl/10 mM Tris/10 mM EGTA, pH 7.0) and, after 5 min, were centrifuged in a Beckman Microfuge B for 4 min (2). The Triton X-100-insoluble pellet was washed twice with buffer, solubilized in Tris buffer containing 2% NaDodSO4 (wt/vol) and 2% 2-mercaptoethanol (wt/vol) and incubated at 100°C for 10 min. Aliquots containing 10-100 ,jg of protein were electrophoresed through slab gels (25) , and proteins were stained with Coomassie brilliant blue.
RESULTS
Low concentrations (0.5-1 uM) of cytochalasin B inhibited the liberation or metabolism, or both, of arachidonic acid in horse platelets stimulated by thrombin (Fig. 1) . In contrast, the release of serotonin was not affected by these concentrations of cytochalasin B. The inhibitory action ofcytochalasin B was considerably more evident on the metabolism of arachidonic acid by cyclooxygenase and lipoxygenase than on the liberation of arachidonic acid from platelet phospholipids or the formation of phosphatidic acid; the formation of the cyclooxygenase product, 12-hydroxy-5,8,10-heptadecatrienoic acid (12-HHT), and the lipoxygenase product, 12-hydroxy-5,8,10,14-icosatetraenoic acid (12-HETE), was affected more drastically than was the formation of phosphatidic acid and the liberation of arachidonic acid (Fig. 2) . The effect ofcytochalasin B was more pronounced at low concentrations of thrombin (0.15 unit/ml compared to 0.5 unit/ml). When the thrombin concentration was raised to 1 unit/ml, which resulted in maximal activation of platelets, even much higher concentrations (100 p.M) of cytochalasin B did not affect the metabolism of arachidonic acid (data not shown). Cytochalasin D produced effects similar to those of cytochalasin B (Fig. 3) . Again, the formation of cyclooxygenase and lipoxygenase products was very strongly inhibited, whereas Phospholipase A2 activity was measured in the total particulate fraction, and phospholipase C activity, in the soluble fraction obtained the formation of phosphatidic acid and 1,2-diacylglycerol plus arachidonic acid were only minimally affected. The thrombin-induced polymerization of actin in human platelets also was inhibited by cytochalasin D (Fig. 4) . The effective concentration range of cytochalasin D which caused the reduction of filamentous actin in the Triton X-100-insoluble platelet cytoskeleton was 1-10 puM (Fig. 4) . Cytochalasin B or D did not inhibit directly the platelet enzyme activities that are involved in the liberation of metabolism of arachidonic acid (Tables 1 and 2 Fig. 4 ). In contrast, cytochalasin does not affect the thrombin-induced release of serotonin (Fig. 1) , indicating a dissociation between actin polymerization and serotonin release.
The data suggest that the mechanism by which cytochalasins interfere with the metabolism of arachidonic acid in thrombinstimulated platelets may be related to the inhibition of actin polymerization by cytochalasins. Notably, cytochalasin B does not directly affect any ofthe platelet enzyme activities involved in the liberation and metabolism of arachidonic acid, such as phospholipase A2, phospholipase C, cyclooxygenase, and lipoxygenase (Table 1) , and exogenously added arachidonic acid is metabolized without interference by intact platelets in the presence of cytochalasins (Table 2) . Thus, the action ofcytochalasin on the metabolism of arachidonic acid is clearly indirect. Furthermore, the inhibition is only observed if the extent of platelet activation is low (0.15-0.5 unit/ml of thrombin in the presence of EGTA or EDTA and with no stirring), and it can be overcome with high thrombin concentrations (1 unit/ml), even in the presence of high concentrations of cytochalasin.
Cytochalasins are known to bind preferentially to actin filaments, and they are believed to prevent further actin polymerization by capping the fast-growing end ofthe actin filament (6) (7) (8) (9) . Recent observations indicate, however, that the action of cytochalasins on actin polymer formation in vitro and cytoskeletal networks in vivo is more complex than believed previously (26, 27) . Resting platelets contain only a few short microfilaments (28-30), whereas activated platelets contain an organized cytoskeletal structure with nets or bundles of microfilaments (2, 27, 28, 30) . In activated platelets, cytochalasins might act by preventing the formation of long filaments or by disrupting the network organization with formation of actin filament foci (27) .
Thrombin stimulates the liberation from membrane phospholipids ofarachidonic acid, which is then rapidly metabolized by cyclooxygenase and lipoxygenase activities (31, 32) . The effects of cytoskeletal disruption on the thrombin-induced formation of cyclooxygenase and lipoxygenase metabolites must occur by interference with the systems by which the liberated arachidonic acid reaches the specific intracellular sites of its metabolism. The fact that free arachidonic acid is not increased could suggest some inhibition of phospholipases of the A2 type or stimulation of reesterification of free arachidonic acid into platelet phospholipids. Alternatively, this also could reflect disruption of a normal positive feedback mechanism between the metabolism and production of arachidonic acid. Notably, the absence of any effects of the cytochalasins on the metabolism of exogenously added arachidonic acid compared to the endogenously produced arachidonic acid stresses dramatically the differences in the metabolic pathways that must exist. Thus, there is strong reason to suspect that endogenously produced arachidonic acid is delivered (or closely coupled) specifically to sites ofthis metabolism and is not released as "free" arachidonic acid. The present studies suggest that polymerization of actin in platelets may be closely linked with the metabolism of arachidonic acid in activated platelets.
